Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like Prime Therapeutics Urges Caution On Mandates Of Abuse-Deterrent Formulations Of Opioids Citing Value Concerns July 20, 2017 Medidata Solutions, Inc. Successfully Hosts Annual Conference Series July 12, 2017 Axovant Strengthens Executive Team With Key Management Appointments June 5, 2017
Prime Therapeutics Urges Caution On Mandates Of Abuse-Deterrent Formulations Of Opioids Citing Value Concerns July 20, 2017
